GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Additional Paid-In Capital

Elixxer (Elixxer) Additional Paid-In Capital : $12.88 Mil(As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer Additional Paid-In Capital?


Elixxer's quarterly additional paid-in capital increased from Mar. 2023 ($12.74 Mil) to Jun. 2023 ($13.12 Mil) but then stayed the same from Jun. 2023 ($13.12 Mil) to Sep. 2023 ($12.88 Mil).

Elixxer's annual additional paid-in capital increased from Dec. 2020 ($10.56 Mil) to Dec. 2021 ($13.02 Mil) but then declined from Dec. 2021 ($13.02 Mil) to Dec. 2022 ($12.83 Mil).

Elixxer Additional Paid-In Capital Historical Data

The historical data trend for Elixxer's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Additional Paid-In Capital Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 7.68 10.56 13.02 12.83

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.49 12.83 12.74 13.12 12.88

Elixxer Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Elixxer Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Elixxer's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixxer (Elixxer) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Additional Paid-In Capital
Comparable Companies
BLMS NEPTF THCT HCANF INLB BGPPF DVLP STMH BBBT DMKPQ XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Website
https://www.elixxer.com
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.